Physician profile
Anna Carolina Wright
NPI 1861261653
$1,111.29
in general payments reported to CMS, 2019-2025
13 companies · $710 in 2025
The $710 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $401 · 2025: $710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,111.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $219.02 | 2024-2025 | Airsupra |
| Lilly USA, LLC | $162.72 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $156.74 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Exact Sciences Corporation | $121.80 | 2024-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.12 | 2025 | Jardiance |
| Phathom Pharmaceuticals, INC. | $68.25 | 2025 | Voquezna |
| Collegium Pharmaceutical, INC. | $63.35 | 2025 | Jornay Pm |
| Amgen INC. | $48.55 | 2024 | Evenity, Prolia, Repatha |
| Glaxosmithkline, LLC. | $47.48 | 2024-2025 | Arexvy, Shingrix |
| Mayne Pharma Commercial LLC | $46.02 | 2025 | |
| Pfizer INC. | $41.05 | 2024-2025 | |
| Dexcom, INC. | $17.03 | 2024 | Dexcom G6 Transmitter |
| Abbvie INC. | $16.16 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.